 |
JOURNAL TOOLS |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
MINERVA OPINION EDITORIAL
Minerva Urology and Nephrology 2021 August;73(4):424-7
DOI: 10.23736/S2724-6051.21.04592-4
Copyright © 2021 EDIZIONI MINERVA MEDICA
lingua: Inglese
Potential utility of a 4-marker immunohistochemistry panel to predict response to cisplatin-based neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a single-center preliminary experience
Simone MORSELLI 1, 2 ✉, Riccardo CAMPI 1, 2, Mauro GACCI 1, 2, Arcangelo SEBASTIANELLI 1, 2, Caterina FATTORINI 3, Donata VILLARI 1, 2, Marco CARINI 2, 4, Andrea MINERVINI 2, 4, Sergio SERNI 1, 2, Maria R. RASPOLLINI 3
1 Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy; 2 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 3 Department of Histopathology and Molecular Diagnostics, Careggi Hospital, University of Florence, Florence, Italy; 4 Unit of Urological Oncologic Minimally-Invasive Robotic Surgery and Andrology, Careggi Hospital, University of Florence, Florence, Italy